메뉴 건너뛰기




Volumn 7, Issue 1, 2007, Pages 57-68

Therapeutic interventions in the glyc(oxid)ation pathway

Author keywords

AGE receptors; Aldose reductase inhibitors (ARI); Aminoguanidine; Glycation; Metformin; Pyridoxamine

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALAGEBRIUM; ALBUMIN; ALDOSE REDUCTASE INHIBITOR; ALT 946; AMINE OXIDE; AMINOGUANIDINE; AROMATIC COMPOUND; BENFOTIAMINE; CANDESARTAN; EPALRESTAT; GROWTH FACTOR; HYDRALAZINE; IRBESARTAN; LOSARTAN; LR 74; LR 9; LR 90; METFORMIN; N (2 ACETAMIDOETHYL)HYDRAZINECARBOXIMIDAMIDE; NIFEDIPINE; OLMESARTAN; PLACEBO; PYRIDOXAMINE; TELMISARTAN; TEMOCAPRILAT; THIAMINE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 34247160755     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152207779802491     Document Type: Review
Times cited : (10)

References (144)
  • 3
    • 0027370108 scopus 로고
    • Trial Research Group
    • Trial Research Group. N. Engl. J. Med. 1993, 329, 977-986.
    • (1993) N. Engl. J. Med , vol.329 , pp. 977-986
  • 4
    • 0032511583 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352, 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 27
  • 137
    • 0035856980 scopus 로고    scopus 로고
    • Brownlee, M. Nature 2001, 414, 813-820.
    • (2001) Nature , vol.414 , pp. 813-820
    • Brownlee, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.